BioLineRx (BLRX) Asset Utilization Ratio (2023 - 2025)
Historic Asset Utilization Ratio for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to 0.31.
- BioLineRx's Asset Utilization Ratio rose 1063.55% to 0.31 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31, marking a year-over-year increase of 1063.55%. This contributed to the annual value of 0.56 for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, BioLineRx's Asset Utilization Ratio is 0.31, which was up 1063.55% from 0.4 recorded in Q2 2025.
- BioLineRx's Asset Utilization Ratio's 5-year high stood at 0.63 during Q4 2024, with a 5-year trough of 0.01 in Q4 2023.
- Its 3-year average for Asset Utilization Ratio is 0.31, with a median of 0.29 in 2024.
- Per our database at Business Quant, BioLineRx's Asset Utilization Ratio surged by 433221.36% in 2024 and then skyrocketed by 1063.55% in 2025.
- Quarter analysis of 3 years shows BioLineRx's Asset Utilization Ratio stood at 0.01 in 2023, then soared by 4332.21% to 0.63 in 2024, then crashed by 51.45% to 0.31 in 2025.
- Its Asset Utilization Ratio stands at 0.31 for Q3 2025, versus 0.4 for Q2 2025 and 0.54 for Q1 2025.